| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Chief Financial Officer | Stock Option (right to buy) | 0 | $218K | $3.35 | Dec 5, 2025 | Direct |
| Mural Oncology plc | Chief Financial Officer | Ordinary Shares | 0 | $0 | $2.07 | Dec 5, 2025 | Direct |
| InMed Pharmaceuticals Inc. | Director | Employee Stock Option (Right to Buy) | 46.4K | Dec 29, 2021 | Direct | ||
| InMed Pharmaceuticals Inc. | Director | Employee Stock Option (Expiration) | 16.1K | Jan 24, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MURA | Mural Oncology plc | Dec 5, 2025 | 3 | $0 | 4 | Dec 5, 2025 | Chief Financial Officer |
| MURA | Mural Oncology plc | Nov 3, 2025 | 1 | -$14.9K | 4 | Nov 10, 2025 | Chief Financial Officer |
| MURA | Mural Oncology plc | Mar 3, 2025 | 2 | $0 | 4 | Mar 5, 2025 | Chief Financial Officer |
| MURA | Mural Oncology plc | Oct 31, 2024 | 1 | -$25.3K | 4 | Nov 1, 2024 | Chief Financial Officer |
| MURA | Mural Oncology plc | Dec 14, 2023 | 2 | $0 | 4 | Dec 18, 2023 | Chief Financial Officer |
| MURA | Mural Oncology plc | Nov 15, 2023 | 0 | $0 | 3 | Nov 15, 2023 | Chief Financial Officer |
| INM | InMed Pharmaceuticals Inc. | Jan 24, 2022 | 3 | $0 | 4 | Jan 24, 2022 | Director |
| INM | InMed Pharmaceuticals Inc. | Dec 29, 2021 | 1 | $0 | 4 | Dec 30, 2021 | Director |